DENTSPLY SIRONA (XRAY) News
NASDAQ: XRAYHealth CareMedical/Dental InstrumentsUSD
8.29-0.20 (-2.36%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
XRAY news summary
We found 13 recent headlines mentioning DENTSPLY SIRONA (XRAY): 1 in the past week and 9 in the past 30 days, most often from Nasdaq, GlobeNewswire, Investing.com. For price context, XRAY is down 2.36% at $8.29. The most recent story, "Dentsply Sirona: 3 Key Takeaways for Long-Term Investors", was published by Nasdaq on Nov 16, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest DENTSPLY SIRONA headlines
- Dentsply Sirona: 3 Key Takeaways for Long-Term InvestorsKey PointsManagement reduced full-year 2026 sales guidance to approximately $3.5 billion.Nasdaq
- DENTSPLY (XRAY) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Why is Dentsply Sirona stock plunging today?Investing.com
- XRAY Stock Declines as Q3 Earnings & Sales Miss Estimates, Outlook CutDENTSPLY SIRONA's Q3 sales decline 7.6% amid dental weakness, while Wellspect growth provides support. The company lowers its 2026 outlook.NasdaqXRAY, BDX, GMED, GKOS
- Dentsply Sirona Non-GAAP EPS of $0.29 misses by $0.02, revenue of $836M misses by $25.65MSeeking Alpha
- Dentsply Sirona Inc Q3 Earnings Summary(RTTNews) - Below are the earnings highlights for Dentsply Sirona Inc (XRAY):Nasdaq
- Dentsply Sirona Reports Third Quarter 2026 ResultsNews SummaryGlobeNewswire
- DENTSPLY SIRONA to Post Q3 Earnings: What's in Store for the Stock?DENTSPLY SIRONA faces Q3 earnings pressure from weak dental demand, tariff costs and segment challenges, while Wellspect's growth may offer some relief.NasdaqXRAY, BDX, GMED, GKOS
- Did Dentsply Sirona Inc. Insiders Breach their Fiduciary Duties to Shareholders?Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be…PR Newswire
- Dentsply Sirona to Host Third Quarter 2026 Conference Call on November 5CHARLOTTE, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and…GlobeNewswire
- XRAY's Q2 Earnings Beat Meets Steady Guidance and Margin PressureXRAY beat Q2 earnings and revenue estimates, held 2026 guidance and improved cash flow, but falling sales and margin pressure cloud the recovery.NasdaqXRAY, ALGN, NVST
- Is HSIC Worth Buying as Growth Improves but Execution Risks Persist?Henry Schein's broader growth, recurring technology revenues and savings plan support its outlook, but leverage and execution risks remain key concerns.NasdaqHSIC, MCK, XRAY
- How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings OutlookAlign's $37.5M U.K. VAT liability, new 20% VAT charges and pending appeal add fresh earnings uncertainty amid currency and mix pressures.NasdaqALGN, XRAY, HSIC